Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients-Reference-Cited by-同舟云学术

Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients

Published:2016-11-08 Issue:11 Volume:17 Page:1861
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Lorente Leonardo,Martín María,Pérez-Cejas Antonia,Barrios Ysamar,Solé-Violán Jordi,Ferreres José,Labarta Lorenzo,Díaz César,Jiménez Alejandro

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/11/1861/pdf

Reference40 articles.

1. Sepsis in European intensive care units: Results of the SOAP study*

2. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

3. Role of Biomarkers in Sepsis Care

4. Increased plasma levels of interleukin-6 in sepsis;Hack;Blood,1989

5. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iraqi patients with a single-nucleotide polymorphism of interleukin-10 -1082G/A and interleukin-6 -174G/C susceptibility to asthma;Asia Pacific Journal of Molecular Biology and Biotechnology;2024-07-30

2. Análisis de las variantes genéticas IL-6 – 174G/C y FNT-α -308 G/A en pacientes con diagnóstico de sepsis bacteriana;Archivos de Medicina (Manizales);2024-02-19

3. Polimorfismos de los genes CCR5, IL-6, IFN-γ e IL-10 en pacientes cubanos con VIH/sida;Revista Clínica Española;2024-02

4. Polymorphisms of CCR5, IL-6, IFN-γ and IL-10 genes in Cuban HIV/AIDS patients;Revista Clínica Española (English Edition);2024-02

5. Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer;npj Breast Cancer;2022-11-11